2007ScienceRequires access

Bank On It

Author information unavailable

Open publisher page 0 citations

Abstract

Supporters of biomedical research have hatched a new scheme to boost the flat budget of the National Institutes of Health (NIH): savings bonds. A bill introduced in the House last week by Representative Steve Pearce (R-NM) and two colleagues would create special Treasury “health research” bonds. When the bond is cashed in, the buyer would forfeit 10% of the interest, which would go to the NIH institute of his or her choice. If officials managed to persuade a fifth of U.S. bond buyers to purchase the special securities, NIH would get $158 million a year—a 0.5% drop in the bucket for the $29 billion NIH but far more than the $7 million a year currently raised by a special breast cancer research stamp. The Association of American Medical Colleges has endorsed the bill, which is now in the Ways and Means Committee.

About this research paper

What this paper is about

Supporters of biomedical research have hatched a new scheme to boost the flat budget of the National Institutes of Health (NIH): savings bonds. A bill introduced in the House last week by Representative Steve Pearce (R-NM) and two colleagues would create special Treasury “health research” bonds. When the bond is cashed in, the buyer would forfeit 10% of the interest, which would go to the NIH institute of his or her choice. If officials managed to persuade a fifth of U.S. bond buyers to purchase the special securities, NIH would get $158 million a year—a 0.5% drop in the bucket for the $29 billion NIH but far more than the $7 million a year currently raised by a special breast cancer research stamp. The Association of American Medical Colleges has endorsed the bill, which is now in the Ways and Means Committee.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Supporters of biomedical research have hatched a new scheme to boost the flat budget of the National Institutes of Health (NIH): savings bonds. A bill introduced in the House last week by Representative Steve Pearce (R-NM) and two colleagues would create special Treasury “health research” bonds. When the bond is cashed in, the buyer would forfeit 10% of the interest, which would go to the NIH institute of his or her choice. If officials managed to persuade a fifth of U.S. bond buyers to purchase the special securities, NIH would get $158 million a year—a 0.5% drop in the bucket for the $29 billion NIH but far more than the $7 million a year currently raised by a special breast cancer research stamp. The Association of American Medical Colleges has endorsed the bill, which is now in the Ways and Means Committee.

Key concepts: Business, Financial system

Related papers

Back to paper searchBrowse research topicsOriginal source
Bank On It — Research Paper | ScholarLens